Neogen launches Reveal® Q+ for Aflatoxin M1
Neogen Corporation (NASDAQ: NEOG) has introduced a new rapid test called Reveal® Q+ for Aflatoxin M1, capable of detecting this cancer-causing toxin in milk at levels as low as 150 parts per trillion (ppt). This innovative test simplifies the detection process for dairy processors by being compatible with the Raptor® Integrated Analysis Platform, which allows for simultaneous testing of aflatoxin M1 and various dairy antibiotics. Aflatoxin M1 is regulated in many countries, including the U.S. and Brazil, with a threshold of 500 ppt.
- Launch of Reveal® Q+ for Aflatoxin M1 test enhances product offerings.
- Test can detect aflatoxin M1 levels as low as 150 ppt, improving safety standards.
- Allows simultaneous testing for aflatoxin M1 and dairy antibiotics, streamlining processes for dairy processors.
- None.
LANSING, Mich., Jan. 12, 2021 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched a quicker, easier test to detect aflatoxin M1, a known cancer-causing toxin of concern to the global dairy industry.
Neogen's new Reveal® Q+ for Aflatoxin M1 can detect as little as 150 parts per trillion (ppt) of the toxin in milk samples in just minutes. The new test is designed for use with Neogen's Raptor® Integrated Analysis Platform, which controls the timing, temperature and reading of the test strips — allowing testers to simply add sample and walk away.
"Our addition of our test to detect aflatoxin M1 with our Raptor system simplifies the testing process for dairy processors, as they can now use our patented Raptor system to simultaneously test for this toxin, as well as dairy antibiotics," said John Adent, Neogen's president and CEO. "Now, dairy processors can simultaneously test one sample for the presence of aflatoxin M1 and classes of dairy antibiotics of known concern, including beta-lactams and tetracyclines. Testing milk samples doesn't get any easier."
Aflatoxin M1 is a carcinogenic metabolite of aflatoxin B1 that is produced in the rumen of dairy cattle. Many countries, including the United States and Brazil, have a regulatory limit of 500 ppt for aflatoxin M1. The new test can detect aflatoxin M1 in milk within a range of 150 to 600 ppt.
Reveal Q+ for Aflatoxin M1 utilizes the same incubation temperature and time as Neogen's BetaStar® antibiotic tests, including tests for beta-lactams (e.g., amoxicillin, ampicillin and penicillin) and tetracyclines. The Raptor platform automatically incubates and analyzes up to three milk samples independently and simultaneously. The system also protects the integrity and consistency of testing data by processing and analyzing results without additional operator input.
Neogen offers the most comprehensive range of food safety diagnostic test products for foodborne bacteria, mycotoxins, dairy antibiotics, food allergens, and other concerns. Its full line of mycotoxin test kits detect aflatoxin, deoxynivalenol (DON), fumonisin, ochratoxin, T-2/HT-2, and zearalenone.
Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in worldwide biosecurity products, animal genomics testing and the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals and veterinary instruments.
CONTACT: | Nate Banner, Neogen Corporation |
517/372-9200, nbanner@neogen.com |
View original content:http://www.prnewswire.com/news-releases/neogen-launches-reveal-q-for-aflatoxin-m1-301206374.html
SOURCE Neogen Corporation
FAQ
What is Neogen Corporation's new product related to aflatoxin M1?
How effective is the new Reveal Q+ test from Neogen in detecting aflatoxin M1?
What regulatory limits exist for aflatoxin M1 in milk?
What advantages does the Raptor platform provide for dairy testing?